Biomarkers in Medicine

Aims & Scope

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes.

These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk.

The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs.

For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers.

However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.1
2024	1.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.493

Quartile

Year	Value
2024	Q3

Journal Rank

Year	Value
2024	11739

Journal Citation Indicator

Year	Value
2024	622

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• PubMed
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Intracellular Coenzymes as Natural Biomarkers for Metabolic Activities and Mitochondrial Anomalies

  Citation: 385

  Authors: Ahmed A

• Exosomes: The Future of Biomarkers in Medicine

  Citation: 329

  Authors: Francesca, Mariantonia, Stefano

• Recommendations to Standardize Preanalytical Confounding Factors in Alzheimer’s and Parkinson’s Disease Cerebrospinal Fluid Biomarkers: An Update

  Citation: 289

  Authors: Marta, Brit, Antonio, Sebastiaan, Harald, Anja Hviid, Elisabeth, Niels, Nathalie, Sylvain, Jose L, Lucilla, Armand, Javier, Esen, Andrea, Eugeen, Marcel, Pieter Jelle, Charlotte

• Current Developments in Salivary Diagnostics

  Citation: 288

  Authors: Craig S, Joseph D, Alison L, Charles L, Roger L, Nicolaos, Pierre N, Glennon, Bryon, James W, Spencer W, Jeffrey L, John T

• Neutrophil Gelatinase-Associated Lipocalin: A� Promising Biomarker for Human Acute Kidney Injury

  Citation: 262

  Authors: Prasad

• Stability of miRNA in Human Urine Supports its Biomarker Potential

  Citation: 187

  Authors: Christine, David M, Blythe, Robert H

• CA125 in Ovarian Cancer

  Citation: 178

  Authors: Nathalie, Nicole

• Brain Inflammation as a Biomarker in Epilepsy

  Citation: 177

  Authors: Annamaria, Alon

• Early Diagnosis of Pancreatic Cancer: Challenges and New Developments

  Citation: 177

  Authors: Sukhwinder, Michael J, Maneesh, Aaron R, Surinder K

• Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease

  Citation: 175

  Authors: Douglas, Thomas J

---